Cue Biopharma to Participate in Fireside Chat at the Citizens Life Sciences Conference
Provided By GlobeNewswire
Last update: May 5, 2025
BOSTON, May 05, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune disease and cancer, today announced that it will participate in a fireside chat at the Citizens Life Sciences Conference being held in New York, May 7-8, 2025.
Read more at globenewswire.com0.777
+0.01 (+1.44%)
Find more stocks in the Stock Screener
CUE Latest News and Analysis
14 days ago - ChartmillWhat's going on in today's after hours sessionLet's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
